Hemodynamic Phenotype-Based,Capillary Refill Time-Targeted Resuscitation In Early Septic Shock:ANDROMEDA-SHOCK-2

Clinical trial NCT06062303 · RECRUITING

Trial details

NCT number: NCT06062303
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Intensive Care Unit Acquired Weakness Shock, Septic

Start date: 2024-02-06
Primary completion: 2025-12-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.